Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2019
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer
Sehui Kim, Ji-Young Jang, Jaemoon Koh, et al.
BMC Cancer
|
January 9, 2019
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
Ryul Kim, Bhumsuk Keam, Sehui Kim, et al.
Blood Advances
|
January 16, 2026
Distribution and prognostic impact of LymphGen subtypes in Korean diffuse large B-cell lymphoma using clinical NGS panel
Jeemin Yim, Sungyoung Lee, Sehui Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2022
TCF1<sup>+</sup>PD-1<sup>+</sup> tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
Jaemoon Koh, Sehui Kim, Yeon Duk Woo, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2021
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues
Shin Hye Yoo, Jihui Yun, Bhumsuk Keam, et al.
Scientific Reports
|
May 24, 2019
Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
Shin Hye Yoo, Bhumsuk Keam, Chan-Young Ock, et al.
Journal for Immunotherapy of Cancer
|
March 6, 2025
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Oncotarget
|
February 20, 2016
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.
Oncotarget
|
December 13, 2017
Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.
Cell
|
June 4, 2019
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma
Jake June-Koo Lee, Seongyeol Park, Hansol Park, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2019
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer
Sehui Kim, Ji-Young Jang, Jaemoon Koh, et al.
BMC Cancer
|
January 9, 2019
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
Ryul Kim, Bhumsuk Keam, Sehui Kim, et al.
Blood Advances
|
January 16, 2026
Distribution and prognostic impact of LymphGen subtypes in Korean diffuse large B-cell lymphoma using clinical NGS panel
Jeemin Yim, Sungyoung Lee, Sehui Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2022
TCF1<sup>+</sup>PD-1<sup>+</sup> tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
Jaemoon Koh, Sehui Kim, Yeon Duk Woo, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2021
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues
Shin Hye Yoo, Jihui Yun, Bhumsuk Keam, et al.
Scientific Reports
|
May 24, 2019
Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
Shin Hye Yoo, Bhumsuk Keam, Chan-Young Ock, et al.
Journal for Immunotherapy of Cancer
|
March 6, 2025
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Oncotarget
|
February 20, 2016
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.
Oncotarget
|
December 13, 2017
Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.
Cell
|
June 4, 2019
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma
Jake June-Koo Lee, Seongyeol Park, Hansol Park, et al.
Page
of 8